Article
07 Aug 2025
Appeal Of Examiner's Final Rejection Of Claims 18-20 Reversed By PTAB
CONTRIBUTING SINCE MAY 2017
Oblon, McClelland, Maier & Neustadt, L.L.P
Oblon is among the largest US law firms that exclusively practice IP law. Businesses worldwide depend on Oblon to establish, protect and leverage their IP assets. Our team of 100+ legal professionals includes some of the country’s most respected practitioners. Most attorneys hold advanced degrees in engineering, physics, chemistry, biotechnology and other scientific disciplines. Oblon is headquartered within steps of the USPTO office in Alexandria, Virginia.
POPULAR TOPICS
Intellectual Property
Food, Drugs, Healthcare, Life Sciences
Technology
COMPANY CONTENT
Article
31 Jul 2025
Federal Circuit Holds Prosecution History Disclaimer Applicable To Design Patents
Article
31 Jul 2025
The PTAB Radically Changes Its Approach To Discretionary Denials
Article
28 Jul 2025
Eye Therapies, LLC. v. Slayback Pharma, LLC: How Prosecution History Can Alter Phrase Interpretation
Article
18 Jul 2025
G1/24: Decision Of The Enlarged Board Of Appeal Of The European Patent Office On Claim Interpretation
Article
01 May 2025
CAFC Weighs In On Machine Learning In Recentive Analytics v. Fox Corp.
Article
29 Apr 2025
Impermissible Hindsight Leads To Reversal Of Obviousness Finding
Article
11 Apr 2025
The Limits Of Inherency In Product-By-Process Claims, And When Is An Isolated Cell Actually A Population?
Article
02 Apr 2025
Prosecution Disclaimer In A Member Of A Patent Family Over The Prosecution History Of Another Member Of The Family
Article
13 Mar 2025
US Synthetic Corp. v. International Trade Commission: Safeguarding Structure And Property Limitations In Composition-of-Matter Claims
Article
13 Mar 2025
WEBINAR: Listing Medical Devices In The Orange Book After Teva v. Amneal (Video)
Article
05 Mar 2025
The Muted Response Of Pharmaceutical Companies To The Establishment Of The Unitary Patent Court
Article
20 Feb 2025
Federal Circuit Reverses District Court's Invalidity Ruling On Written Description In Novartis v. Torrent
Article
18 Feb 2025
PTAB Reverses Examiner Based On "Or" Language
Article
14 Feb 2025
Using Espacenet.com For Retrieving References
Article
12 Feb 2025
Patenting Of Multi-Disciplinary Subject Matter – Personalized Medicine
Article
17 Jan 2025
The CAFC Backs The FTC View On Listing Device Patents In The Orange Book
Article
07 Jan 2025
A Transformation Of Matter Helps Secure Subject Matter Eligibility At The PTAB
Article
05 Dec 2024
USPTO Withdraws Proposed Changes To Terminal Disclaimer Practice
Article
26 Nov 2024
USPTO Announces Fee Increases Effective January 19, 2025
